Mehsana, 30th December 2023, : Emcure Pharmaceuticals, one of India’s leading pharma companies, inaugurated its recently commissioned facility at Mehsana in Gujarat. The inauguration was done by Shri. Rushikeshbhai Patel, Honourable Minister of Health and Family Welfare, Gujarat. The new plant manufactures injectables for sale in India as well as for export to global markets.
Emcure’s manufacturing operations have been established for decades, and are spread across 13 sites in India. The company currently has an oral formulations manufacturing line at Mehsana and the new unit commissioned in August, 2023 is now ready for commercial supplies to domestic and international markets.
With dedicated manufacturing facilities for different platforms and packaging formats, Emcure’s manufacturing facilities across the country are capable of producing pharmaceutical and biopharmaceutical products across a wide range of dosage forms, including oral solids, oral liquids, injectables, including liposomal and lyophilized injectables, biotherapeutics and complex APIs. With approvals and accreditations from various regulatory authorities such as EDQM, Health Canada, USFDA, ANVISA Brazil, and more, the company ensures that it remains in compliance with the relevant regulations and is able to supply products in regulated and other markets.
Rushikeshbhai Patel, Honourable Minister of Health and Family Welfare, Government of Gujarat praised Emcure’s commitment towards providing accessible and affordable healthcare and said, “The inauguration of the new manufacturing plant by Emcure Pharmaceuticals in Mehsana, Gujarat marks a pivotal moment in India’s pursuit of providing quality pharmaceutical products for both the Indian and international markets. This facility, equipped with the latest technology and adherence to quality control measures, underscores their dedication to ensuring that each product meets and exceeds global pharmaceutical benchmarks.”
Emcure’s new manufacturing plant will aim at creating additional job opportunities in the local market.
Speaking on the occasion, Satish Mehta, Founder and CEO, Emcure Pharmaceuticals said, “The new Mehsana facility represents our continued investment in Gujarat, aligning with our vision to bring solutions to address the unmet medical needs and improve patient outcomes globally. We believe that the new capacity addition will help meet the growing demand for our differentiated product portfolio across markets.”